Related Experiment Video

Updated: Jun 25, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.7K

Review of late-breaking clinical trials from Cardiovascular Research Technologies (CRT) 2024

Ilan Merdler1, Kalyan R Chitturi1, Jason P Wermers1

  • 1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America.

Cardiovascular Revascularization Medicine : Including Molecular Interventions
|May 25, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Artificial intelligenceCoronary artery diseaseDrug-coated balloonHypertrophic cardiomyopathyPercutaneous coronary interventionPeripheral vascular diseaseRenal denervationTranscatheter aortic valve implantationTranscatheter aortic valve replacement

More Related Videos

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model11:49

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model

Published on: September 9, 2011

20.4K
Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

2.6K

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
157